Adults with chronic pain who participated in New York State’s (NYS) Medical Cannabis Program were significantly less likely to require prescription opioids, according to a new...
Seven years after medical cannabis was legalised in the UK, new data from Releaf sheds light on how the treatment is changing patients’ lives, but also...
German pharmaceutical company Vertanical believes it is on course to deliver the first ‘whole-plant’, cannabis medicine with international approval. After seven years of endeavour, and an...
A new survey of NHS doctors has highlighted a growing demand for alternative treatment options for complex health issues.
Scientists have developed a new compound to harnesses the pain-relieving properties of cannabis without any unwanted side effects, pointing to a possible alternative to opioids. In...
In a survey of 250 practicing doctors in the UK, 84% said they would be open to prescribing if it was part of the NHS toolkit.
A new study suggests that adults aged 65 and older experience “considerable improvements” in their health and wellbeing when prescribed cannabis-based medicines. The use of medical...
Early economic analysis suggests that at the right price point, cannabis-based medicines could offer a cost-effective alternative for chronic pain.
Medical cannabis was rated as more positive in terms of emotional and holistic effects.
37% of GPs surveyed believe that medical cannabis has the potential to reduce patient dependency on other medications.
